Cargando…

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era

BACKGROUND: To assess the role of radiotherapy in metastatic malignant melanoma (MM) patients in modern era. MATERIALS AND METHODS: This is a retrospective study of MM patients treated with radiotherapy at Mayo Clinic from 1999 to 2014. Patients with pre- and post-treatment imaging studies (CT, MRI,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Youland, Ryan S., Blanchard, Miran L., Dronca, Roxanna, Kottschade, Lisa, Markovic, Svetomir N., Olivier, Kenneth R., Park, Sean S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862645/ https://www.ncbi.nlm.nih.gov/pubmed/29594220 http://dx.doi.org/10.1016/j.ctro.2017.09.002

Ejemplares similares

18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma
por: Youland, Ryan S., et al.
Publicado: (2017)

Bim and PD-1 identify effector CD8 T cells responsive to anti-PD-1 therapy in metastatic melanoma patients
por: Dronca, Roxana, et al.
Publicado: (2015)

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients
por: Vera Aguilera, Jesus, et al.
Publicado: (2020)

Therapy for metastatic melanoma: the past, present, and future
por: Finn, Laura, et al.
Publicado: (2012)

Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992–2011
por: Enninga, Elizabeth Ann L., et al.
Publicado: (2017)

Primary Intracranial Malignant Melanoma with Extracranial Metastasis
por: Hirota, Kengo, et al.
Publicado: (2017)

The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma
por: Mansfield, Aaron S., et al.
Publicado: (2013)

Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG‐N0377, Alliance)
por: Vera Aguilera, Jesus, et al.
Publicado: (2018)

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
por: Yan, Yiyi, et al.
Publicado: (2018)

Expansion of CD16-Negative Natural Killer Cells in the Peripheral Blood of Patients with Metastatic Melanoma
por: Holtan, Shernan G., et al.
Publicado: (2011)

Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations
por: DeLeon, Thomas T., et al.
Publicado: (2020)

Brachial Plexus Neuritis Associated With Anti–Programmed Cell Death-1 Antibodies: Report of 2 Cases
por: Alhammad, Reem M., et al.
Publicado: (2017)

Dominant effects of Δ40p53 on p53 function and melanoma cell fate
por: Takahashi, Rie, et al.
Publicado: (2013)

Primary cerebral malignant melanoma in insular region with extracranial metastasis: case report and review literature
por: Troya-Castilla, Marta, et al.
Publicado: (2016)

OR32-02 Immune Checkpoint Inhibitor-Induced Hypophysitis Is Associated with Improved Overall Survival in Cancer Patients
por: Kotwal, Anupam, et al.
Publicado: (2020)

Development and validation of a unifying pre-treatment decision tool for intracranial and extracranial metastasis-directed radiotherapy
por: Kowalchuk, Roman, et al.
Publicado: (2023)

Understanding heterogeneous tumor microenvironment in metastatic melanoma
por: Yan, Yiyi, et al.
Publicado: (2019)

Synergy between early-incorporation immunotherapy and extracranial radiotherapy in metastatic non-small cell lung cancer
por: Chodavadia, Parth A., et al.
Publicado: (2021)

Extracranial doses in stereotactic and conventional radiotherapy for pituitary adenomas
por: Ram, Thomas Samuel, et al.
Publicado: (2006)

Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma
por: Valpione, Sara, et al.
Publicado: (2015)

Extracranial systemic antitumor response through the abscopal effect induced by brain radiation in a patient with metastatic melanoma
por: D’Andrea, Mark A., et al.
Publicado: (2019)

Metastatic prostate cancer in the modern era of PSA screening
por: Fontenot, Philip A., et al.
Publicado: (2017)

Limited recurrence distance of glioblastoma under modern radiotherapy era
por: Tu, Ziwei, et al.
Publicado: (2021)

Advancements of radiotherapy for recurrent head and neck cancer in modern era
por: Zhang, Shu, et al.
Publicado: (2023)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy (SBRT) for an Extracranial Arteriovenous Malformation of the Pelvis
por: Jooya, Alborz, et al.
Publicado: (2021)

Rescuing Cancer Immunity by Plasma Exchange in Metastatic Melanoma (ReCIPE-M1): protocol for a single-institution, open-label safety trial of plasma exchange to clear sPD-L1 for immunotherapy
por: Davidson, Tara M, et al.
Publicado: (2022)

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy
por: Teterycz, Pawel, et al.
Publicado: (2020)

Radiotherapy for malignant melanoma of the lacrimal sac
por: Cheng, Tiffany W, et al.
Publicado: (2020)

Immuno-transcriptomic profiling of extracranial pediatric solid malignancies
por: Brohl, Andrew S., et al.
Publicado: (2021)

Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases
por: In, Gino K., et al.
Publicado: (2020)

Immune checkpoint molecules soluble program death ligand 1 and galectin‐9 are increased in pregnancy
por: Enninga, Elizabeth Ann L., et al.
Publicado: (2017)

Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events
por: Isik, Busra, et al.
Publicado: (2021)

Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy
por: Galli, Filippo, et al.
Publicado: (2020)

Cancer immune control dynamics: a clinical data driven model of systemic immunity in patients with metastatic melanoma
por: Frisch, Harold P., et al.
Publicado: (2021)

Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis
por: Poon, Ian, et al.
Publicado: (2020)

From Melanocyte to Metastatic Malignant Melanoma
por: Bandarchi, Bizhan, et al.
Publicado: (2010)

From Melanocyte to Malignant Metastatic Melanoma
por: Manga, Prashiela, et al.
Publicado: (2010)

Current and Emerging Therapeutic Approaches for Extracranial Malignant Rhabdoid Tumors
por: Nemes, Karolina, et al.
Publicado: (2022)

Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer
por: Ollivier, Luc, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n64nu3e2j49s3o8uhf5pa24kop